NICE
NICE Ltd.
NICE's fundamentals are mixed, but it looks cheap: trading at 14x earnings, less than half its usual 50x. Analysts expect earnings growth.
NICE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
NICE's revenue, profitability, cash flow and balance sheet are all currently healthy.
NICE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 14x | $94.12 | — |
| Cheap | 17x | $116 | +23% |
| Fair | 49x | $341 | +263% |
| Expensive | 76x | $522 | +454% |
Historical ranges are pointers, not guarantees.
NICE's PE is in its cheap range at 14x.
NICE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for NICE, with profitability holding steady.
NICE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $6.90 | -18% |
| Q1 2026 | $8.43 | +18% |
| Q4 2025 | $9.67 | +43% |
| Q3 2025 | $8.80 | +36% |
| Q2 2025 | $8.37 | +40% |
| Q1 2025 | $7.17 | +29% |
| Q4 2024 | $6.76 | +33% |
| Q3 2024 | $6.46 | +31% |
NICE earned $6.90 per share over the past year, down 18% from the year before.
NICE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $795.7M | +9.5% |
| Q1 2026 | $766.5M | +9.5% |
| Q4 2025 | $786.5M | +9% |
| Q3 2025 | $732M | +6.1% |
| Q2 2025 | $726.7M | +9.4% |
| Q1 2025 | $700.2M | +6.2% |
| Q4 2024 | $721.6M | +16% |
| Q3 2024 | $690M | +15% |
NICE's revenue has grown year over year every quarter since late 2020: $796M last quarter, up 9.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 14% | -8.3 points |
| Q1 2026 | 16% | -4.7 points |
| Q4 2025 | 22% | +1 points |
| Q3 2025 | 22% | +1.5 points |
| Q2 2025 | 22% | +2.7 points |
| Q1 2025 | 21% | +2.7 points |
| Q4 2024 | 21% | +1.7 points |
| Q3 2024 | 20% | +1.6 points |
NICE's operating margin was 14% last quarter, down 8.3 points from the same quarter a year ago.
NICE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $117.3M | +204% |
| Q1 2026 | $169.4M | -36% |
| Q4 2025 | $156M | -31% |
| Q3 2025 | $163.6M | +24% |
| Q2 2025 | $38.6M | -74% |
| Q1 2025 | $264.6M | +16% |
| Q4 2024 | $225.1M | +40% |
| Q3 2024 | $131.7M | +28% |
NICE generated $606M in free cash flow over the past year, down 8.2% from the year before.
NICE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2% | -1.2M shares |
| 1 year | -6% | -3.8M shares |
| 3 years | -11% | -7M shares |
| 5 years | -11% | -7.1M shares |
| Available history | -8.7% | -5.7M shares |
NICE has 59M diluted shares, down 6% from a year ago, with $519M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q2 2026 | $60.8M |
| Q1 2026 | $252.6M |
| Q4 2025 | $165.2M |
| Q3 2025 | $40.6M |
| Q2 2025 | $30.8M |
| Q1 2025 | $252.3M |
| Q4 2024 | $95.2M |
| Q3 2024 | $86.4M |
NICE spent $519M buying back its own shares over the past year, up 12% from the year before.
NICE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | 0.0x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.1x | Net Cash |
NICE has more cash than debt.
NICE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.9 | Neutral |
| Stochastic | 24.3 | Neutral |
NICE's weekly RSI is 43 (neutral) and its Stochastic is 24 (neutral).
NICE PE vs Technology Sector
| Metric | NICE | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 28x | 51% below |
| PE % | 13 | 35 | 22 pts below |
NICE is trading at 14x earnings, a 51% discount to the Technology sector's median of 28x.
NICE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $110.2 | 15% below |
| 20 week MA | $104.5 | 9.9% below |
| 50 week MA | $105.3 | 11% below |
| 100 week MA | $128.5 | 27% below |
| 200 week MA | $162.8 | 42% below |
NICE is in a downtrend: it's below all five of its weekly moving averages, and 42% below its 200-week average.
NICE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $156.3 | $279.8 | +79% |
| 2021 | $279.8 | $306.4 | +9.5% |
| 2022 | $306.4 | $194.7 | -36% |
| 2023 | $194.7 | $199.5 | +2.5% |
| 2024 | $199.5 | $173.5 | -13% |
| 2025 | $173.5 | $112.7 | -35% |
| 2026 YTD | $112.7 | $94.1 | -16% |
NICE has finished lower in three of the last six years. It's down 16% so far in 2026.